{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:44:52Z","timestamp":1768441492179,"version":"3.49.0"},"reference-count":39,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Context: Autoimmune polyendocrine syndrome type 1 (APS1) is an autosomal recessive disorder caused by mutations in the autoimmune regulator gene. Hypoparathyroidism occurs in 80% of patients with APS1 and has been suggested to result from an autoimmune reaction against the calcium-sensing receptor (CaSR) on parathyroid cells. However, the detection of CaSR antibodies in APS1 remains controversial, with some studies disputing the relevance of the receptor as an autoantigen.<\/jats:p>\n               <jats:p>Objective: The aim of this study was to analyze a defined set of APS1 patient sera for the presence of CaSR antibodies using different assay systems.<\/jats:p>\n               <jats:p>Results: APS1 patients and individuals with other autoimmune disorders along with healthy subjects were tested for antibody binding to the CaSR. In an immunoprecipitation assay with the CaSR expressed in human embryonic kidney 293 cells, 12 of 14 (85.7%) APS1 and two of 28 (7.1%) Graves\u2019 disease patients were considered positive for CaSR antibodies. The prevalence of receptor antibodies was significantly greater than that in the cohort of healthy individuals only in the APS1 patient group (P &amp;lt; 0.0001). In a flow cytometry assay, seven of 14 (50.0%) APS1 patient sera showed binding to the extracellular domain of the CaSR. The prevalence of receptor antibodies in the APS1 patient group was significantly greater than that in the group of healthy controls (P = 0.023). No CaSR antibodies could be detected in any patients or controls using a radiobinding assay.<\/jats:p>\n               <jats:p>Conclusion: The CaSR is an autoantigen in APS1, but detection of antibodies against the receptor appears to be influenced by the assay system used.<\/jats:p>","DOI":"10.1210\/jc.2006-2466","type":"journal-article","created":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T00:20:30Z","timestamp":1174436430000},"page":"2107-2114","source":"Crossref","is-referenced-by-count":101,"title":["The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1"],"prefix":"10.1210","volume":"92","author":[{"given":"Nikos G.","family":"Gavalas","sequence":"first","affiliation":[{"name":"Section of Endocrinology and Reproduction (N.G.G., E.H.K., P.F.W., A.P.W.), School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield S10 2JF, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Helen","family":"Kemp","sequence":"additional","affiliation":[{"name":"Section of Endocrinology and Reproduction (N.G.G., E.H.K., P.F.W., A.P.W.), School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield S10 2JF, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai J. E.","family":"Krohn","sequence":"additional","affiliation":[{"name":"Department of Pathology (K.J.E.K.), Institute of Medical Technology, University of Tampere, Tampere 33101, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes and Hypertension, and Membrane Biology Program (E.M.B.), Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip F.","family":"Watson","sequence":"additional","affiliation":[{"name":"Section of Endocrinology and Reproduction (N.G.G., E.H.K., P.F.W., A.P.W.), School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield S10 2JF, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P.","family":"Weetman","sequence":"additional","affiliation":[{"name":"Section of Endocrinology and Reproduction (N.G.G., E.H.K., P.F.W., A.P.W.), School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield S10 2JF, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613355068500_R1","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/jc.2005-2611","article-title":"Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.","volume":"91","author":"Perheentupa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1297-399","article-title":"An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains.","volume":"17","year":"1997","journal-title":"Nat Genet"},{"key":"2020071613355068500_R3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene.","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"key":"2020071613355068500_R4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng0994-83","article-title":"An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21.","volume":"8","author":"Aaltonen","year":"1994","journal-title":"Nat Genet"},{"key":"2020071613355068500_R5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/hmg\/8.2.259","article-title":"Localization of the APECED protein in distinct nuclear structures.","volume":"8","author":"Bjorses","year":"1999","journal-title":"Hum Mol Genet"},{"key":"2020071613355068500_R6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0968-0004(98)01231-6","article-title":"The APECED polyglandular autoimmune syndrome protein, AIRE-1, contains the SAND domain and is probably a transcription factor.","volume":"23","author":"Gibson","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"2020071613355068500_R7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0968-0004(00)88957-4","article-title":"The PHD finger: implications for chromatin-mediated transcriptional regulation.","volume":"20","author":"Aasland","year":"1995","journal-title":"Trends Biochem Sci"},{"key":"2020071613355068500_R8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3928\/0090-4481-19800401-07","article-title":"Autoimmune polyglandular syndromes.","volume":"9","author":"Neufeld","year":"1980","journal-title":"Pediatr Ann"},{"key":"2020071613355068500_R9","first-page":"323","article-title":"Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison\u2019s disease.","volume":"78","author":"Uibo","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R10","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0140-6736(92)91829-W","article-title":"21-Hydroxylase, a major autoantigen in idiopathic Addison\u2019s disease.","volume":"339","author":"Winqvist","year":"1992","journal-title":"Lancet"},{"key":"2020071613355068500_R11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/0140-6736(92)91894-E","article-title":"Identification by molecular cloning of an autoantigen associated with Addison\u2019s disease as steroid 17\u03b1-hydroxylase.","volume":"339","author":"Krohn","year":"1992","journal-title":"Lancet"},{"key":"2020071613355068500_R12","first-page":"1488","article-title":"Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.","volume":"81","author":"Tuomi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R13","first-page":"4434","article-title":"\u03b2-Cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.","volume":"85","author":"Gylling","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(97)11050-9","article-title":"Identification of tryptophan hydroxylase as an intestinal autoantigen.","volume":"352","author":"Ekwall","year":"1998","journal-title":"Lancet"},{"key":"2020071613355068500_R15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/bbrc.1999.1945","article-title":"Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I.","volume":"267","author":"Hedstrand","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071613355068500_R16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0014-5793(97)00797-7","article-title":"Cytochrome P450IA2 and aromatic l-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I.","volume":"412","author":"Gebre-Medhin","year":"1997","journal-title":"FEBS Lett"},{"key":"2020071613355068500_R17","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.1074\/jbc.M102391200","article-title":"The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type 1.","volume":"276","author":"Hedstrand","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071613355068500_R18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jbmr.5650010512","article-title":"Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells.","volume":"1","author":"Posillico","year":"1986","journal-title":"J Bone Miner Res"},{"key":"2020071613355068500_R19","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1073\/pnas.83.21.8366","article-title":"Antibodies to bovine parathyroid cells in autoimmune hypoparathyroidism.","volume":"83","author":"Brandi","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613355068500_R20","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1073\/pnas.85.11.4015","article-title":"Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism.","volume":"85","author":"Fattorossi","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613355068500_R21","first-page":"353","article-title":"Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions.","volume":"62","author":"Betterle","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"2020071613355068500_R22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI118513","article-title":"Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism.","volume":"97","author":"Li","year":"1996","journal-title":"J Clin Invest"},{"key":"2020071613355068500_R23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterisation of an extracellular Ca2+-sensing receptor from bovine parathyroid.","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"2020071613355068500_R24","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1210\/jc.2004-0021","article-title":"Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism.","volume":"89","author":"Mayer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R25","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1210\/jc.2003-030700","article-title":"The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex.","volume":"88","author":"Gylling","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jc.2003-030279","article-title":"Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I.","volume":"89","author":"Soderbergh","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R27","doi-asserted-by":"crossref","first-page":"19537","DOI":"10.1074\/jbc.271.32.19537","article-title":"Expression and characterisation of inactivating and activating mutations in the human Ca2+o-sensing receptor.","volume":"271","author":"Bai","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071613355068500_R28","author":"Sambrook","year":"1989"},{"key":"2020071613355068500_R29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071613355068500_R30","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1021\/bi0107389","article-title":"Purification and characterisation of a soluble bioactive amino-terminal extracellular domain of the human thyrotropin receptor.","volume":"40","author":"Cornelis","year":"2001","journal-title":"Biochemistry"},{"key":"2020071613355068500_R31","doi-asserted-by":"crossref","first-page":"20763","DOI":"10.1074\/jbc.M107788200","article-title":"Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex.","volume":"277","author":"Newby","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071613355068500_R32","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1074\/jbc.270.21.12919","article-title":"Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs.","volume":"270","author":"Garrett","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071613355068500_R33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2003-031054","article-title":"Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism.","volume":"89","author":"Kifor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/eje.0.1500009","article-title":"Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism.","volume":"150","author":"Goswami","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2020071613355068500_R35","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1210\/jcem.82.4.3895","article-title":"Thyrotropin receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription\/translation system.","volume":"82","author":"Prentice","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613355068500_R36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<586::AID-DIA624>3.0.CO;2-B","article-title":"Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complications.","volume":"15","author":"Hermitte","year":"1998","journal-title":"Diabet Med"},{"key":"2020071613355068500_R37","first-page":"119","article-title":"The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism.","volume":"1","author":"Blizzard","year":"1966","journal-title":"Clin Exp Immunol"},{"key":"2020071613355068500_R38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1677\/joe.0.1650173","article-title":"Non-Ca2+-homeostatic functions of the extracellular Ca2+-sensing receptor (CaR) in endocrine tissues.","volume":"165","author":"Squires","year":"2000","journal-title":"J Endocrinol"},{"key":"2020071613355068500_R39","first-page":"2944","article-title":"Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1.","volume":"85","author":"Ekwall","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/6\/2107\/10780315\/jcem2107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/6\/2107\/10780315\/jcem2107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:12:01Z","timestamp":1594944721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/6\/2107\/2597391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-2466","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}